Patents by Inventor Bryan Walser

Bryan Walser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240037539
    Abstract: A cloud-based service is provided that receives conditions for obtaining an object of value from an enterprise. A blockchain-based media of value is created on a blockchain for the object of value. A smart contract is generated an initiated on the blockchain to enforce the conditions with control over the blockchain-based media of value. When a customer provides actions or information that satisfies the conditions to the smart contract the smart contract returns the blockchain-based media of value to a customer wallet. The customer exchanges the blockchain-based media of value for the object of value from the enterprise. In an embodiment, the blockchain-based media of value is a non-fungible token (NFT).
    Type: Application
    Filed: July 29, 2022
    Publication date: February 1, 2024
    Inventors: Bryan Walser Nonni, Alexander Simon Lewin, Brent Vance Zucker
  • Publication number: 20230342757
    Abstract: A Financial Institution (FI) funds a FI wallet with government-backed currency. The currency is transferred to an equivalent amount of United Stated Dollar (USD) coins. A customer of the bank utilizes an enhanced application (app) that permits value transfers between or associated with Centralized Financial (CeFi) services and Decentralized Financial (DeFi) services using the government-backed currency in the USD coins held by a cloud service and a cryptocurrency wallet held by the cloud service on behalf of the customer for value transfers associated with the DeFi services. Value transfers into and out of the cryptocurrency wallet is managed between interaction of the enhanced app, the cloud service, and the DeFi services. Value transfers into and out of the FI wallet is managed between interaction of the FI, the enhanced app, and the cloud service.
    Type: Application
    Filed: April 21, 2022
    Publication date: October 26, 2023
    Inventor: Bryan Walser Nonni
  • Publication number: 20230298034
    Abstract: A cloud-based service creates and maintains custodial digital wallets for parties to value transfers. Each wallet funded by the corresponding party with cryptocurrency and/or a fiat currency. The cloud-based service provides value transfers between two parties having custodial wallets without any on-chain blockchain operations making such transfers nearly instantaneous. The cloud-based service also provides transfers between one party with a custodial wallet and another party without a custodial wallet by using a liquidity wallet and/or a liquidity account to perform the transfers nearly instantaneously and by initiating any needed blockchain operations on the blockchain to properly reflect any debit or redemption made from the liquidity wallet on the blockchain.
    Type: Application
    Filed: March 15, 2022
    Publication date: September 21, 2023
    Inventor: Bryan Walser Nonni
  • Publication number: 20230120350
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Application
    Filed: September 20, 2022
    Publication date: April 20, 2023
    Inventors: Bryan Walser, Howard V. Raff
  • Publication number: 20230100880
    Abstract: When a consumer checkouts out, the transaction interface presents a buy now pay later option selected by the consumer for payment of a transaction. Consumer information is collected through the interface and a registered financial institution (FI) is presented the transaction details and information for servicing a loan. Terms are provided from the FI and presented to the consumer through the interface. Acceptance by the consumer causes a smart contract with the terms and parties of the loan to be generated in a blockchain (BC) and payment processed by the BC by transferring funds from a FI wallet to a retailer wallet associated with the transaction.
    Type: Application
    Filed: September 29, 2021
    Publication date: March 30, 2023
    Inventors: Bryan Walser Nonni, Abdulwahab Jarkas
  • Publication number: 20230032782
    Abstract: A consumer obtains a consent credential for a given retailer. The consent credential identifies receipt data, which the consumer is authorizing the retailer to obtain. A consumer engages in a wallet-to-wallet transaction with a retailer utilizing Decentralized Identifiers (DIDs) for the wallets of the consumer and the retailer. Receipt data is produced by a payment service on behalf of the retailer, the receipt data is signed by an issuing authority associated with the retailer and delivered as a receipt credential to the consumer. The receipt data is not maintained by the payment service nor the retailer. The retailer requests the receipt data after from the consumer after payment is processed for the transaction by the payment service. The consumer authorizes the request or denies the request, when authorized the receipt credential and corresponding authorized portions of the receipt data are provided from the consumer to the retailer.
    Type: Application
    Filed: October 14, 2022
    Publication date: February 2, 2023
    Inventors: Bryan Walser Nonni, Alexander Simon Lewin
  • Publication number: 20220261789
    Abstract: Centralized Financial (CeFi) services of a Financial Institution (FI) application (app) is enhanced such that the customer can access Decentralized Financial (DeFi) services via the app utilizing a cloud service. The customer preregistered Personal Identification Information (PII) with a Self-Sovereign Identity (SII) provider. When a customer attempts to access a DeFi service, the cloud service intervenes and establishes a Decentralized Identity (DID) based connection between a wallet of the customer and a wallet of the FI through the provider. The FI challenges the identity of the customer and requests that a portion of the PII be shared for Know Your Customer (KYC) requirements, the customer shares, and the SII provides a certification and the portion of the PII back to the FI. The FI stores the certification in a customer record as evidence that KYC requirements were satisfied before the customer accesses the DeFi service from the FI's app.
    Type: Application
    Filed: April 29, 2022
    Publication date: August 18, 2022
    Inventor: Bryan Walser Nonni
  • Publication number: 20220253833
    Abstract: A customer engages a Financial Institution (FI) for access to an account or a service associated with the account of the customer over a first channel of communication. A decentralized identifier (DID) connection is established between a FI wallet and a Self-Sovereign Identity (SSI)-enabled customer wallet. A structured message that is cryptographically signed is sent from the FI wallet to the customer wallet over a secure channel of communication. The message requests authorization of the customer or requests specific Personal Identifiable Information (PII) of the customer. The customer responds via the customer wallet and a second structured message is cryptographically signed and sent to the FI wallet over the secure channel of communication. When the second structured message is authenticated by the FI, the customer is approved for access to the account or approved for access to the service over the first channel of communication.
    Type: Application
    Filed: April 29, 2022
    Publication date: August 11, 2022
    Inventors: Bryan Walser Nonni, Alexander Simon Lewin
  • Publication number: 20220245652
    Abstract: A consumer obtains a consent credential for a given retailer. The consent credential identifies receipt data, which the consumer is authorizing the retailer to obtain. A consumer engages in a wallet-to-wallet transaction with a retailer utilizing Decentralized Identifiers (DIDs) for the wallets of the consumer and the retailer. Receipt data is produced by a payment service on behalf of the retailer, the receipt data is signed by an issuing authority associated with the retailer and delivered as a receipt credential to the consumer. The receipt data is not maintained by the payment service nor the retailer. The retailer requests the receipt data after from the consumer after payment is processed for the transaction by the payment service. The consumer authorizes the request or denies the request, when authorized the receipt credential and corresponding authorized portions of the receipt data are provided from the consumer to the retailer.
    Type: Application
    Filed: January 29, 2021
    Publication date: August 4, 2022
    Inventors: Bryan Walser Nonni, Alexander Simon Lewin
  • Patent number: 11141352
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: October 12, 2021
    Assignee: Société des Produit Nestlé S.A.
    Inventors: Bryan Walser, Howard V. Raff
  • Patent number: 11072830
    Abstract: The present invention relates to methods and systems for assessing the overall risk of a human female subject for developing a breast cancer phenotype. In particular, the present invention relates to combining clinical risk assessment and genetic risk assessment to improve risk analysis.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: July 27, 2021
    Assignee: GENETIC TECHNOLOGIES LIMITED
    Inventors: David A. Hinds, Bryan Walser
  • Publication number: 20210052722
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Application
    Filed: April 7, 2020
    Publication date: February 25, 2021
    Applicant: Aimmune Therapeutics, Inc.
    Inventors: Bryan WALSER, Howard V. RAFF
  • Patent number: 10653773
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: May 19, 2020
    Assignee: Aimmune Therapeutics, Inc.
    Inventors: Bryan Walser, Howard V. Raff
  • Publication number: 20200129378
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Application
    Filed: June 26, 2019
    Publication date: April 30, 2020
    Applicant: Aimmune Therapeutics, Inc.
    Inventors: Bryan WALSER, Howard V. RAFF
  • Patent number: 10512686
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: December 24, 2019
    Assignee: Aimmune Therapeutics, Inc.
    Inventors: Bryan Walser, Howard V. Raff
  • Patent number: 10449118
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Grant
    Filed: October 24, 2017
    Date of Patent: October 22, 2019
    Assignee: AIMMUNE THERAPEUTICS, INC.
    Inventors: Bryan Walser, Howard V. Raff
  • Publication number: 20190192652
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Application
    Filed: February 28, 2019
    Publication date: June 27, 2019
    Applicant: Aimmune Therapeutics, Inc.
    Inventors: Bryan WALSER, Howard V. RAFF
  • Publication number: 20190175723
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Application
    Filed: August 23, 2018
    Publication date: June 13, 2019
    Applicant: Aimmune Therapeutics, Inc.
    Inventors: Bryan WALSER, Howard V. RAFF
  • Patent number: 10086068
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Grant
    Filed: September 26, 2016
    Date of Patent: October 2, 2018
    Assignee: Aimmune Therapeutics, Inc.
    Inventors: Bryan Walser, Howard V. Raff
  • Publication number: 20180080089
    Abstract: The present invention relates to methods and systems for assessing the overall risk of a human female subject for developing a breast cancer phenotype. In particular, the present invention relates to combining clinical risk assessment and genetic risk assessment to improve risk analysis.
    Type: Application
    Filed: November 15, 2017
    Publication date: March 22, 2018
    Applicant: Genetic Technologies Limited
    Inventors: David A. Hinds, Bryan Walser